The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index; 89 of the 188 sources its claims cite were checked for support.
Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound?
Open accessAbstract
The 20-hydroxyecdysone (20E) has been used in traditional medicine for a long time and acquired attention in the last decade as a food supplement and stimulant in physical activities. This polyhydroxylated cholesterol is found in the highest concentration in plants, and it is one of the secondary plant products that has a real hormonal influence in arthropods. Various beneficial effects have been reported in vivo and in vitro for 20E and its related compounds in mammals. Trials for the safety of clinical application showed a remarkably high tolerance in humans. This review aims to assess the latest development in the involvement of various pathways in tissues and organs and look if it is plausible to find a single primary target of this compound. The similarities with agents mimicking calorie restriction and anti-aging effects are also elucidated and discussed.
Overview
CoChat Summary
## TL;DR
This review argues that 20-hydroxyecdysone (20E) affects many tissues and pathways in mammals, with evidence for anabolic, anti-inflammatory, anti-oxidant, anti-obesity, and anti-diabetic effects. The paper concludes that 20E likely does not have a single primary molecular target in vivo, but its effects overlap in part with calorie restriction mimetics.
## Key findings
- In skeletal muscle, 20E increased protein synthesis in murine C2C12 myotubes and human primary myotubes by up to 20%, and in mice it increased grip strength; these effects were prevented by PI3K inhibition.
- In a 10-week resistance-training study in young volunteers, an ecdysterone-containing supplement increased muscle size and one-repetition bench press performance, with no biomarkers of liver or kidney toxicity detected.
- In bone and cartilage, 20E stimulated osteogenic differentiation and dose-dependently induced markers such as ALP, Runx2, osteocalcin, and type I collagen; in an ovariectomized rat model, it increased tibial bone mineral density and alleviated osteoporosis symptoms.
- In metabolic models, oral 20E reduced body weight, hyperglycaemia, plasma insulin, and insulin resistance in high-fat-diet mice; in STZ-induced diabetic rats, 5 mg/kg/day for 30 days lowered glucose, HbA1C, and insulin and improved lipid parameters.
- The review states that 20E influenced multiple pathways including PI3K/Akt/mTOR, ERβ/MAS receptor, Sirt6/NF-κB, and AMPK/ACC, and that its calorie-restriction-like effects overlap with CRMs but are not identical.
## Methods
- This is a narrative review of published in vitro, in vivo, and limited clinical studies on 20E in mammals.
- The authors state that references were collected from PubMed and Google.
- The main analysis is a comparative synthesis of reported molecular targets, tissue-level effects, and overlaps with calorie restriction mimetics and anti-aging mechanisms.
## Limitations
- The paper explicitly notes that none of the suggested molecular targets has been proven to connect directly in vivo.
- It also states that finding a single primary target is difficult because 20E appears to act systemically across tissues.
- Evident from the text: most evidence summarized is from cell culture and animal models, with only limited human trial data mentioned, so translation to humans remains uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
68 Valid · 9 Not valid · 96 Not checked · 34 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Pharmacological compounds mimicking calorie restriction (CRM) became widely used in the medication of metabolic diseases as a substitute for decreased calorie intake [88].”
§ Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? > 2. Cell, Tissue, and Systematic Action > 2.6. Calorie Restriction Mimetics and 20E Additionally, 20E appeared to decrease body weight and adiposity and improve lipid parameters similar to calorie restriction (CR). CR is a method of deliberate reduction in food intake with 10–50% with careful avoidance of malnutrition, that is, providing a sufficient amount of macro- and microelements, vitamins, and dietary fibres [77]. It has an established beneficial effect on health and life span in laboratory animal models from yeast to rhesus monkeys [78,79]. It also appears to be a promising method to improve health conditions and extend healthy life in humans [80]. A two-year-long clinical trial with CR called CALERIE (Comprehensive Assessment of Long Term Effects of Reducing Caloric Intake) led to a straightforward conclusion about the anti-aging effects, including weight loss, improvement in cardiovascular risk parameters, and an increase in insulin sensitivity in healthy non-obese adults [81]. It was also recognized that diet composition (the protein/carbohydrate ratio) and adherence to diet restrictions influenced the risk parameters [82,83]. The age-related DNA methylation pattern in long-term calorie restrictions [84] and the telomere attrition were also interestingly complicating the scene about the potential effect [85]. However, the long-term outcomes of CR still remain to be explored for the role in improving human health, protecting against age-related ailments and diseases, and extending healthy lifespan [86]. It has been recognized that certain metabolic pathways and signal transductions are involved in the mechanism of CR action [87]. Pharmacological compounds mimicking calorie restriction (CRM) became widely used in the medication of metabolic diseases as a substitute for decreased calorie intake [88]. Although the mechanisms of action of CRMs are diverse and not always properly revealed yet, it can be stated that these typically achieve weight loss, change metabolic rates, prevent accumulation of reactive oxygen species, and influence pathways that are also activated in calorie restriction. These pathways are mostly, but not entirely, the insulin/insulin-like growth factor, the target of rapamycin (TOR), the adenosine monophosphate-activated protein kinase (AMPK), and the Sirtuin signalling [78]. There are more than 20 compounds with reported CRM effects (reviewed in [58]), among them are, for example, the metformin used for more than 60 years to ameliorate diabetes. Here belongs resveratrol, the naturally occurring polyphenol, 2-deoxyglucose, and the inhibitor of glycolysis, nicotinamide mononucleotide (NMN) and nicotinamide riboside (NMR), which are constituents of many foods like pork or vegetables and curcumin. A compound of oriental spice, hydroxyl citric acid (HCA), an inhibitor of ATP-citrate lyase found in leaves of Garcinia species in the South Asian region, alpha-ketoglutarate, a key factor and regulator of the TCA cycle, and aspirin, an analgesic, antipyretic, and non-steroidal anti-inflammatory drug that inhibits the cyclooxygenase pathway, are all considered as CRM. Although the CRMs target different pathways and are used to ameliorate a variety of pathological conditions, they are all assumed to have anti-aging effect [58]. Although it is debated if they indeed extend the entire life span, the anti-aging benefit is recognized as the elongation of the period spent in good health, “healthspan”, like in the case of metformin [89]. Although most of the mechanisms of CRM actions are still subjects of investigations, it can be noted that they influence similar cellular pathways and pathological conditions as 20-hydroxyecdysone does (Figure 2). One can be curious if 20E might be a CRM in mammals. Indeed, quite a few examples have been reported about influence on enzymes, pathways that are also activated in CR. Ovariectomized rats fed with a thigh-fat, high-fructose diet (OHFFD) are animal models of “metabolic dysfunction-associated fatty liver disease” (MAFLD), a non-alcoholic fatty liver disease. Dietary supplementation of 20E in OHFFD increased the phosphorylation of AMPK and acetyl-CoA carboxylase while reducing the expression of fatty acid synthase in liver and adipose tissue. Moreover, 20E also increased expression of carnitine palmitoyltransferase-1 in the liver and reduced expression of sterol regulatory element-binding protein-1 in adipose tissue. The above alterations decreased fatty acid biosynthesis and lipogenesis and increased lipolysis/beta-oxidation; therefore, 20E ameliorated hepatic steatosis combined with overweight, diabetes, or other metabolic risk factors, and this was achieved without altering calorie intake in OHFFD rats [90]. This effect was similar to that of Pioglitazone (PIO), a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist. Not incidentally, PIO is a CRM to ameliorate steatosis; however, with unwanted side effects [91]. Sirtuins, one of the main targets of CRMs, have been reported only once in interaction with 20E. Endothelin cells grown in 3-D culture (HUVECs) had been treated with TNF-α, which induced CD40 expression via NF-κB activity. This mechanism starts inflammation because CD40 is inducing IF-β, an inflammatory factor. NF-κB p65 acts in an acetylated form but becomes deacetylated by Sirt6, a nucleus localized protein, therefore decreasing its activity. In docking experiments, 20E binds to Sirt6 and stimulates its expression and also stabilizes it in HUVECs. This scenario protects against endothelial inflammation [13] and is similar to the anti-inflammatory feature exerted by some CRMs, like metformin, curcumin, and alpha-ketoglutarate [58].
What the sources say
- Disputedcites [88] Hofer, S.J., Davinelli, S., Bergmann, M., Scapagnini, G., and Madeo, F. (2021). Caloric Restriction Mimetics in Nutrition and Clinical Trials. Front. Nutr., 8. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says experimental CRM candidates are rare in clinical research and hold promise for medical use, contrary to the claim that they have become widely used as medication. The Abstract says candidates may mimic some effects of calorie restriction without cutting calories, but does not describe established treatment of metabolic diseases. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, 20E-induced hypertrophy and protein synthesis were prevented by GPCR inhibitor in differentiating C2C12 myoblasts [9,10].”
§ Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? > 1. Introduction Phytoecdysteroids have been found to exert mostly beneficial effects on mammals. In fact, hardly any detrimental results have been observed after the administration of these compounds [1,2,3]. This is in contrast to steroid hormones that are endogenous in mammals that usually accompany the positive anabolic effect with an often dangerous androgenic one [4,5,6]. Phytoecdysteroids seem to be pure anabolic, and many plants that contain them are traditionally used in phytomedicine [1,7,8]. This property has generated remarkable attention in the past decades from not only the side of natural compound research but also sport and medical science. In vitro experiments have identified several molecular targets for the most investigated phytoecdysteroid, the 20-hydroxyecdysone (20E, beta-ecdysterone, ecdysterone, beta-ecdysone, and moulting hormone; Figure 1). First, 20E-induced hypertrophy and protein synthesis were prevented by GPCR inhibitor in differentiating C2C12 myoblasts [9,10]. The hypertrophying effect of 20E on these cells was similar to that of the beta-oestrogen and was prevented by the beta-oestrogen receptor-selective antagonist. However, no direct binding of 20E has been demonstrated to the beta-oestrogen receptor [11], and involvement of a membrane-bound receptor was supported by the effectiveness of a protein-bound 20E [12]. Interestingly, angiotensin 1–7, the endogenous ligand of the MAS receptor, had a similar effect on hypertrophy of C2C12 myogenic cells as 20E did. The endogenous muscle growth inhibitor myostatin was partially declined by 20E or angiotensin 1–7. The effects of both ligands were abolished by a specific antagonist of angiotensin 1–7. MAS receptor, as the protective arm of the renin–angiotensin system (RAS), appeared feasible to interpret pleiotropy; therefore, a cooperative activity between MAS and a palmitoylated (membrane-bound) estrogenic receptor has been proposed for the mechanism of 20E action in a RAAS—renin–angiotensin–aldosterone system [1,12]. Recently, it has been shown that 20E exerts its effect through SIRT6-mediated deacetylation of NF-κB p65 (nuclear factor kappa of B cells) to inhibit CD40 expression in 3-D human endothelial cell culture (HUVEC). Therefore, the authors proposed that 20E may have therapeutic potential for the treatment of cardiovascular diseases [13]. In animal studies, 20E revealed anabolic, anti-oxidant, antidiabetic, anti-obesity, cardioprotective, neuroprotective, hepatoprotective, and other properties. It seems so that the multiple effects can be better explained by more than just one molecular target. In fact, as research expands, the pleiotropy of action and the complexity of the mechanism appear to increase. Highlighting overlaps and sometimes opposites of these in vitro and in vivo mechanisms in the different tissues, organs, and conditions is the main topic of this review. References have been collected from PubMed and Google. A number of citations revealed that 20E has anti-obesity effect and many similarities in the influenced molecular pathways and alleviated pathological conditions with a circle of compounds proposed for mimicking calorie restriction (CRM) and seeking an anti-aging effect. The discussion of these commonalities is where this overview aims to conclude.
What the sources say
- Partly supportedcites [9] Cohick, 2010, Ecdysteroids elicit a rapid Ca2+ flux leading to Akt activation and increased protein synthesis in skeletal muscle cells, Steroids sourceExperimental — accuracy not yet measured
The Results (Protein Synthesis; page not provided) report that pretreatment with PTX completely abolished the 20HE-induced increase in protein synthesis. But the Cell Culture section says the experiments used differentiated C2C12 myotubes, not differentiating myoblasts; the paper identifies PTX as a G-protein inhibitor and does not report that it prevented hypertrophy. (LLM, conf=0.90)
- Could not verifycites [10] Zhao, 2020, G protein-coupled receptors function as cell membrane receptors for the steroid hormone 20-hydroxyecdysone, Cell Commun. Signal sourceExperimental — accuracy not yet measured
The 20E signaling cascade via GPCRs section discusses 20E-mediated signaling in H. armigera, not differentiating C2C12 myoblasts. Searches for C2C12, hypertrophy, and a GPCR inhibitor found no passage reporting that an inhibitor prevented 20E-induced hypertrophy or protein synthesis; the References list only a separate study whose title mentions increased protein synthesis in skeletal muscle cells. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This is in contrast to steroid hormones that are endogenous in mammals that usually accompany the positive anabolic effect with an often dangerous androgenic one [4,5,6].”
§ Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? > 1. Introduction Phytoecdysteroids have been found to exert mostly beneficial effects on mammals. In fact, hardly any detrimental results have been observed after the administration of these compounds [1,2,3]. This is in contrast to steroid hormones that are endogenous in mammals that usually accompany the positive anabolic effect with an often dangerous androgenic one [4,5,6]. Phytoecdysteroids seem to be pure anabolic, and many plants that contain them are traditionally used in phytomedicine [1,7,8]. This property has generated remarkable attention in the past decades from not only the side of natural compound research but also sport and medical science. In vitro experiments have identified several molecular targets for the most investigated phytoecdysteroid, the 20-hydroxyecdysone (20E, beta-ecdysterone, ecdysterone, beta-ecdysone, and moulting hormone; Figure 1). First, 20E-induced hypertrophy and protein synthesis were prevented by GPCR inhibitor in differentiating C2C12 myoblasts [9,10]. The hypertrophying effect of 20E on these cells was similar to that of the beta-oestrogen and was prevented by the beta-oestrogen receptor-selective antagonist. However, no direct binding of 20E has been demonstrated to the beta-oestrogen receptor [11], and involvement of a membrane-bound receptor was supported by the effectiveness of a protein-bound 20E [12]. Interestingly, angiotensin 1–7, the endogenous ligand of the MAS receptor, had a similar effect on hypertrophy of C2C12 myogenic cells as 20E did. The endogenous muscle growth inhibitor myostatin was partially declined by 20E or angiotensin 1–7. The effects of both ligands were abolished by a specific antagonist of angiotensin 1–7. MAS receptor, as the protective arm of the renin–angiotensin system (RAS), appeared feasible to interpret pleiotropy; therefore, a cooperative activity between MAS and a palmitoylated (membrane-bound) estrogenic receptor has been proposed for the mechanism of 20E action in a RAAS—renin–angiotensin–aldosterone system [1,12]. Recently, it has been shown that 20E exerts its effect through SIRT6-mediated deacetylation of NF-κB p65 (nuclear factor kappa of B cells) to inhibit CD40 expression in 3-D human endothelial cell culture (HUVEC). Therefore, the authors proposed that 20E may have therapeutic potential for the treatment of cardiovascular diseases [13]. In animal studies, 20E revealed anabolic, anti-oxidant, antidiabetic, anti-obesity, cardioprotective, neuroprotective, hepatoprotective, and other properties. It seems so that the multiple effects can be better explained by more than just one molecular target. In fact, as research expands, the pleiotropy of action and the complexity of the mechanism appear to increase. Highlighting overlaps and sometimes opposites of these in vitro and in vivo mechanisms in the different tissues, organs, and conditions is the main topic of this review. References have been collected from PubMed and Google. A number of citations revealed that 20E has anti-obesity effect and many similarities in the influenced molecular pathways and alleviated pathological conditions with a circle of compounds proposed for mimicking calorie restriction (CRM) and seeking an anti-aging effect. The discussion of these commonalities is where this overview aims to conclude.
What the sources say
- Partly supportedcites [4] Hunyadi, 2008, Phytoecdysteroids and anabolic-androgenic steroids—Structure and effects on humans, Curr. Med. Chem. sourceExperimental — accuracy not yet measured
The 'Anabolic Steroid Effect in Muscle' section reports anabolic effects of testosterone, and 'Anabolic-Androgenic Steroids' says complete separation of anabolic and androgenic effects was impossible. Those sections support the pairing of effects, but do not establish that the androgenic effect is often dangerous. Page numbers are unavailable in our copy. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [5] Hunyadi, 2010, Phytoecdysteroids and vitamin D analogues—Similarities in structure and mode of action, Curr. Med. Chem. source
- Partly supportedcites [6] Berger, 2024, Long-term effects of doping with anabolic steroids during adolescence on physical and mental health, Orthopadie sourceExperimental — accuracy not yet measured
The Introduction says anabolic steroids are used to improve performance, and Somatic effects describes harmful effects of AAS use, including virilization and infertility. These passages concern administered steroids in doping; they do not establish that endogenous mammalian steroid hormones usually pair an anabolic effect with a dangerous androgenic one. No page numbers are available in our copy. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Phytoecdysteroids have been found to exert mostly beneficial effects on mammals. In fact, hardly any detrimental results have been observed after the administration of these compounds [1,2,3].”
§ Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? > 1. Introduction Phytoecdysteroids have been found to exert mostly beneficial effects on mammals. In fact, hardly any detrimental results have been observed after the administration of these compounds [1,2,3]. This is in contrast to steroid hormones that are endogenous in mammals that usually accompany the positive anabolic effect with an often dangerous androgenic one [4,5,6]. Phytoecdysteroids seem to be pure anabolic, and many plants that contain them are traditionally used in phytomedicine [1,7,8]. This property has generated remarkable attention in the past decades from not only the side of natural compound research but also sport and medical science. In vitro experiments have identified several molecular targets for the most investigated phytoecdysteroid, the 20-hydroxyecdysone (20E, beta-ecdysterone, ecdysterone, beta-ecdysone, and moulting hormone; Figure 1). First, 20E-induced hypertrophy and protein synthesis were prevented by GPCR inhibitor in differentiating C2C12 myoblasts [9,10]. The hypertrophying effect of 20E on these cells was similar to that of the beta-oestrogen and was prevented by the beta-oestrogen receptor-selective antagonist. However, no direct binding of 20E has been demonstrated to the beta-oestrogen receptor [11], and involvement of a membrane-bound receptor was supported by the effectiveness of a protein-bound 20E [12]. Interestingly, angiotensin 1–7, the endogenous ligand of the MAS receptor, had a similar effect on hypertrophy of C2C12 myogenic cells as 20E did. The endogenous muscle growth inhibitor myostatin was partially declined by 20E or angiotensin 1–7. The effects of both ligands were abolished by a specific antagonist of angiotensin 1–7. MAS receptor, as the protective arm of the renin–angiotensin system (RAS), appeared feasible to interpret pleiotropy; therefore, a cooperative activity between MAS and a palmitoylated (membrane-bound) estrogenic receptor has been proposed for the mechanism of 20E action in a RAAS—renin–angiotensin–aldosterone system [1,12]. Recently, it has been shown that 20E exerts its effect through SIRT6-mediated deacetylation of NF-κB p65 (nuclear factor kappa of B cells) to inhibit CD40 expression in 3-D human endothelial cell culture (HUVEC). Therefore, the authors proposed that 20E may have therapeutic potential for the treatment of cardiovascular diseases [13]. In animal studies, 20E revealed anabolic, anti-oxidant, antidiabetic, anti-obesity, cardioprotective, neuroprotective, hepatoprotective, and other properties. It seems so that the multiple effects can be better explained by more than just one molecular target. In fact, as research expands, the pleiotropy of action and the complexity of the mechanism appear to increase. Highlighting overlaps and sometimes opposites of these in vitro and in vivo mechanisms in the different tissues, organs, and conditions is the main topic of this review. References have been collected from PubMed and Google. A number of citations revealed that 20E has anti-obesity effect and many similarities in the influenced molecular pathways and alleviated pathological conditions with a circle of compounds proposed for mimicking calorie restriction (CRM) and seeking an anti-aging effect. The discussion of these commonalities is where this overview aims to conclude.
What the sources say
- Partly supportedcites [1] Dinan, L., Dioh, W., Veillet, S., and Lafont, R. (2021). 20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases. Biomedicines, 9. sourceExperimental — accuracy not yet measured
The Conclusions and Prospects section (page unavailable) says that 20-hydroxyecdysone (20E) has many beneficial effects in mammals and is non-toxic. It also says 20E is the only ecdysteroid investigated to any extent, so the paper does not establish the claim for phytoecdysteroids generally. (LLM, conf=0.87)
- Partly supportedcites [2] Dioh, 2023, A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults, J. Cachexia Sarcopenia Muscle sourceExperimental — accuracy not yet measured
The Introduction reports beneficial activity in animal models and low toxicity for 20-hydroxyecdysone (20E). The Discussion’s safety section also describes BIO101, a 20E preparation, as well tolerated in healthy volunteers, although mild or moderate adverse events occurred. These passages support the claim for 20E but do not establish it for phytoecdysteroids as a group. (LLM, conf=0.86)
- Partly supportedcites [3] Lobo, 2024, Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): A randomized, placebo-controlled, phase 2/3 trial, EClinicalMedicine sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports a benefit and a favorable safety profile for BIO101, a 20-hydroxyecdysone treatment, in adults hospitalized with severe COVID-19. The Safety outcomes section also reports treatment-related adverse events, so the paper does not establish the broader claim that phytoecdysteroids generally have mostly beneficial effects and hardly any detrimental results across mammals. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“therefore, a cooperative activity between MAS and a palmitoylated (membrane-bound) estrogenic receptor has been proposed for the mechanism of 20E action in a RAAS—renin–angiotensin–aldosterone system [1,12].”
§ Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? > 1. Introduction Phytoecdysteroids have been found to exert mostly beneficial effects on mammals. In fact, hardly any detrimental results have been observed after the administration of these compounds [1,2,3]. This is in contrast to steroid hormones that are endogenous in mammals that usually accompany the positive anabolic effect with an often dangerous androgenic one [4,5,6]. Phytoecdysteroids seem to be pure anabolic, and many plants that contain them are traditionally used in phytomedicine [1,7,8]. This property has generated remarkable attention in the past decades from not only the side of natural compound research but also sport and medical science. In vitro experiments have identified several molecular targets for the most investigated phytoecdysteroid, the 20-hydroxyecdysone (20E, beta-ecdysterone, ecdysterone, beta-ecdysone, and moulting hormone; Figure 1). First, 20E-induced hypertrophy and protein synthesis were prevented by GPCR inhibitor in differentiating C2C12 myoblasts [9,10]. The hypertrophying effect of 20E on these cells was similar to that of the beta-oestrogen and was prevented by the beta-oestrogen receptor-selective antagonist. However, no direct binding of 20E has been demonstrated to the beta-oestrogen receptor [11], and involvement of a membrane-bound receptor was supported by the effectiveness of a protein-bound 20E [12]. Interestingly, angiotensin 1–7, the endogenous ligand of the MAS receptor, had a similar effect on hypertrophy of C2C12 myogenic cells as 20E did. The endogenous muscle growth inhibitor myostatin was partially declined by 20E or angiotensin 1–7. The effects of both ligands were abolished by a specific antagonist of angiotensin 1–7. MAS receptor, as the protective arm of the renin–angiotensin system (RAS), appeared feasible to interpret pleiotropy; therefore, a cooperative activity between MAS and a palmitoylated (membrane-bound) estrogenic receptor has been proposed for the mechanism of 20E action in a RAAS—renin–angiotensin–aldosterone system [1,12]. Recently, it has been shown that 20E exerts its effect through SIRT6-mediated deacetylation of NF-κB p65 (nuclear factor kappa of B cells) to inhibit CD40 expression in 3-D human endothelial cell culture (HUVEC). Therefore, the authors proposed that 20E may have therapeutic potential for the treatment of cardiovascular diseases [13]. In animal studies, 20E revealed anabolic, anti-oxidant, antidiabetic, anti-obesity, cardioprotective, neuroprotective, hepatoprotective, and other properties. It seems so that the multiple effects can be better explained by more than just one molecular target. In fact, as research expands, the pleiotropy of action and the complexity of the mechanism appear to increase. Highlighting overlaps and sometimes opposites of these in vitro and in vivo mechanisms in the different tissues, organs, and conditions is the main topic of this review. References have been collected from PubMed and Google. A number of citations revealed that 20E has anti-obesity effect and many similarities in the influenced molecular pathways and alleviated pathological conditions with a circle of compounds proposed for mimicking calorie restriction (CRM) and seeking an anti-aging effect. The discussion of these commonalities is where this overview aims to conclude.
What the sources say
- Partly supportedcites [1] Dinan, L., Dioh, W., Veillet, S., and Lafont, R. (2021). 20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases. Biomedicines, 9. sourceExperimental — accuracy not yet measured
In the section discussing 20E’s mode of action (page unavailable), the paper proposes that 20E acts through the membrane Mas1 receptor, which interacts with an estrogen receptor (ERx) on the inner side of the plasma membrane. It proposes this mechanism for myostatin regulation in muscle cells; the passages do not describe ERx as palmitoylated or place the proposed mechanism in the renin–angiotensin–aldosterone system. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [12] Lafont, 2021, 20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor, J. Mol. Endocrinol. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
93 more claims · 30 with their cited sources checked
Create a free account to see all 207 claims and every source verdict.
- It may state two separate claims as one. 98
- Probably not a substantial claim. 14
- The quote only partly states this claim. 4
Citations
Cites
Caloric restriction improves health and survival of rhesus monkeys
Mattison, J. A., Colman, R. J., Beasley, T. M., Allison, D. B., Kemnitz, J. W., Roth, G. S., Ingram, D. K., Weindruch, R., de Cabo, R., & Anderson, R. M. (2017) · Nature Communications · doi:10.1038/ncomms14063 · Cited by 838 · cited 1×
“It has an established beneficial effect on health and life span in laboratory animal models from yeast to rhesus monkeys [78,79].”
Functionally significant insulin-like growth factor I receptor mutations in centenarians
Suh, Y., Atzmon, G., Cho, M.-O., Hwang, D., Liu, B., Leahy, D. J., Barzilai, N., & Cohen, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705467105 · Cited by 703 · cited 1×
“The activity of IGF-1/IGFR that elevates PI3K/Akt/mTor has been shown to act against longevity in animal [110] and human studies [111,112].”
Calorie restriction in humans: An update
Most, J., Tosti, V., Redman, L. M., & Fontana, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.005 · Cited by 530 · cited 1×
“It also appears to be a promising method to improve health conditions and extend healthy life in humans [80].”
Ravussin, E., Redman, L. M., Rochon, J., Das, S. K., Fontana, L., Kraus, W. E., Romashkan, S., Williamson, D. A., Meydani, S. N., Villareal, D. T., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv057 · Cited by 489 · cited 1×
“…called CALERIE (Comprehensive Assessment of Long Term Effects of Reducing Caloric Intake) led to a straightforward conclusion about the anti-aging effects, including weight loss, improvement in cardiovascular risk parameters, and an increase in insulin sensitivity in healthy non-obese adults [81].”
Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice
Mitchell, S. J., Madrigal-Matute, J., Scheibye-Knudsen, M., Fang, E., Aon, M., González-Reyes, J. A., Cortassa, S., Kaushik, S., Gonzalez-Freire, M., Patel, B., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.027 · Cited by 451 · cited 1×
“CR is a method of deliberate reduction in food intake with 10–50% with careful avoidance of malnutrition, that is, providing a sufficient amount of macro-and microelements, vitamins, and dietary fibres [77].”
Endocrine regulation of ageing
Russell, S. J., & Kahn, C. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2234 · Cited by 356 · cited 1×
“The activity of IGF-1/IGFR that elevates PI3K/Akt/mTor has been shown to act against longevity in animal [110] and human studies [111,112].”
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria
Ryu, K. W., Fung, T. S., Baker, D. C., Saoi, M., Park, J., Febres-Aldana, C. A., Aly, R. G., Cui, R., Sharma, A., Fu, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08146-w · Cited by 284 · cited 1×
“Recently Recently, it has been reported that starving cells can overcome the difficulty of balancing catabolic and anabolic processes using the fusion and fission cycle to sequester a subset of mitochondria specialized on synthetic processes instead of oxidative phosphorylation [102].”
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · cited 2×
“Although it is debated if they indeed extend the entire life span, the anti-aging benefit is recognized as the elongation of the period spent in good health, “healthspan”, like in the case of metformin [89].”
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., De Miguel, Z., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 221 · cited 1×
“The monoaminergic system is related to memory loss and decline in cognitive function in neurological symptoms as Parkinsons and Alzheimers diseases [49].”
Machado, S. A., Pasquarelli-do-Nascimento, G., da Silva, D. S., Farias, G. R., de Oliveira Santos, I., Baptista, L. B., & Magalhães, K. G. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00694-0 · Cited by 220 · cited 1×
“Besides metabolic consequences, such transformation also has an endocrine impact [107].”
Cited by
Gholipour, P., Komaki, A., Parsa, H., & Ramezani, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05168-x · Cited by 11
“Moreover, HIIT has been shown to reverse amyloid-beta-induced LTP deficits, with these effects attenuated by pharmacological inhibition of mTOR, demonstrating the pathway’s crucial role in exercise-mediated neuroplasticity [118].”
Padkao, T., & Prasertsri, P. (2025) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk10020202 · Cited by 2
“Most investigations into the effects of 20E on endothelial function have been conducted in animal models such as mice, rats, and ovine [44].”
Bidirectional effect of ecdysterone on thymocyte volume regulation and proliferation
Salimova, F. A., Rustamova, S. I., Khojiboev, S. A., Khamidova, O. J., Merzlyak, P. G., Fayziev, D. D., Syrov, V. N., Эгамова, Ф. Р., Kurbannazarova, R. S., & Sabirov, R. Z. (2025) · Steroids · doi:10.1016/j.steroids.2025.109653 · Cited by 3
Osman, A. A., Laczkó, D., Vágvölgyi, M., Tóth, N., Kemény, K. K., Szatmári, P., Seres-Bokor, A., Hunyadi, A., & Ducza, E. (2026) · Nutrients · doi:10.3390/nu18122023
“For 20E, previous studies have shown enhancement of lipophagy [26], improvement in glucose tolerance and insulin sensitivity, suppression of adipogenesis [33,34], and inhibition of hepatic gluconeogenesis [35].”
Jara, M. R. A., Cruz, R. Y. M. S., Bautista, K. G., Landeo, E. C., Cáceres, E. E. C., Molero, H. R. L., Segovia, J. C. P., Rashid, A., & Aurora‐Prado, M. S. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.70014
Metadata
- Authors
- Zádor, E.
- Affiliations
- University of Szeged (HU)
- Corresponding author
- Zádor, Ernő
- ORCID
- Zádor, Ernő
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2025-03-13
- Volume
- 14
- Issue
- 6
- Pages
- 431
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC11941724
- OpenAlex
- W4408404235
- Cited by
- 9
- References
- 111
- Citations by year
- 2026: 5 · 2025: 4
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- EU-funded Hungarian grant (EFOP-3.6.2-16-2017-00006)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- 20-hydroxyecdysone, molecular targets, mechanism of action, caloric restriction mimetics, anti-aging, secondary plant products, dietary supplements, safety and tolerability
- MeSH terms
- Aging, Animals, Ecdysterone, Humans, Mammals, Caloric Restriction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? https://app.cochat.ai/papers/10.3390/cells14060431
- The paper
- Zádor, E. (2025). Molecular Targets of 20-Hydroxyecdysone in Mammals, Mechanism of Action: Is It a Calorie Restriction Mimetic and Anti-Aging Compound? Cells. https://doi.org/10.3390/cells14060431
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.